search
Back to results

Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital (IVIO)

Primary Purpose

Cardiac Arrest

Status
Recruiting
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Intraosseous access
Intravenous
Sponsored by
Lars Wiuff Andersen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiac Arrest

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Out-of-hospital cardiac arrest
  2. Age ≥ 18 years
  3. Indication for intravenous or intraosseous vascular access during cardiac arrest

Exclusion Criteria:

  1. Blunt or penetrating traumatic cardiac arrest
  2. Prior enrollment in the trial
  3. Intravenous or intraosseous vascular access already in place and working when the first trial-participating unit arrives on site

Sites / Locations

  • Emergency Medical Services, the North Denmark RegionRecruiting
  • Prehospital Emergency Medical Services, Central Denmark RegionRecruiting
  • Copenhagen Emergency Medical Services, the Capital Region of Denmark
  • Emergency Medical Services, the Region of Southern DenmarkRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Intravenous

Intraosseous

Arm Description

The intervention will consist of attempts to successfully establish a peripheral intravenous access during the cardiac arrest. The prehospital clinician will be required to attempt the intervention a minimum of two times.

The intervention will consist of attempts to successfully establish an intraosseous access during the cardiac arrest. The prehospital clinician will be required to attempt the intervention a minimum of two times.

Outcomes

Primary Outcome Measures

Sustained return of spontaneous circulation
Palpable pulses or other signs of circulation without a need for chest compressions lasting at least 20 minutes

Secondary Outcome Measures

Survival
Favorable neurological outcome
Neurological outcome will be assessed with the modified Rankin Scale (mRS) which is a scale from 0 to 6 assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes. The scale will will be dichotomized as favorable (mRS 0-3) vs. unfavorable (mRS 4-6).

Full Information

First Posted
January 11, 2022
Last Updated
August 10, 2023
Sponsor
Lars Wiuff Andersen
Collaborators
Central Denmark Region, University of Aarhus
search

1. Study Identification

Unique Protocol Identification Number
NCT05205031
Brief Title
Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital
Acronym
IVIO
Official Title
Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest - A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 1, 2022 (Actual)
Primary Completion Date
February 28, 2024 (Anticipated)
Study Completion Date
February 28, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Lars Wiuff Andersen
Collaborators
Central Denmark Region, University of Aarhus

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The "Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital Cardiac Arrest (IVIO)"-trial is an investigator-initiated, randomized, parallel group, patient and outcome assessor-blinded, superiority trial of intravenous vs. intraosseous vascular access during adult out-of-hospital cardiac arrest. The intraosseous group will be further randomized to humeral vs. tibial access. The trial will be conducted in the Central Denmark Region. The primary outcome will be sustained return of spontaneous circulation, and 762 patients will be included. Key secondary outcomes include survival at 30 days and survival at 30 days with a favorable neurological outcome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Arrest

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
1262 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intravenous
Arm Type
Active Comparator
Arm Description
The intervention will consist of attempts to successfully establish a peripheral intravenous access during the cardiac arrest. The prehospital clinician will be required to attempt the intervention a minimum of two times.
Arm Title
Intraosseous
Arm Type
Experimental
Arm Description
The intervention will consist of attempts to successfully establish an intraosseous access during the cardiac arrest. The prehospital clinician will be required to attempt the intervention a minimum of two times.
Intervention Type
Device
Intervention Name(s)
Intraosseous access
Intervention Description
Needle placed in the bone marrow.
Intervention Type
Device
Intervention Name(s)
Intravenous
Intervention Description
Needle placed in a vein.
Primary Outcome Measure Information:
Title
Sustained return of spontaneous circulation
Description
Palpable pulses or other signs of circulation without a need for chest compressions lasting at least 20 minutes
Time Frame
Before or after hospital arrival (up to 2 hours after the cardiac arrest)
Secondary Outcome Measure Information:
Title
Survival
Time Frame
30 days after the cardiac arrest
Title
Favorable neurological outcome
Description
Neurological outcome will be assessed with the modified Rankin Scale (mRS) which is a scale from 0 to 6 assessing neurological/functional outcomes after brain damage with higher scores indicating worse neurological/functional outcomes. The scale will will be dichotomized as favorable (mRS 0-3) vs. unfavorable (mRS 4-6).
Time Frame
30 days after the cardiac arrest

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Out-of-hospital cardiac arrest Age ≥ 18 years Indication for intravenous or intraosseous vascular access during cardiac arrest Exclusion Criteria: Blunt or penetrating traumatic cardiac arrest Prior enrollment in the trial Intravenous or intraosseous vascular access already in place and working when the first trial-participating unit arrives on site
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lars W Andersen
Phone
+4551781511
Email
lwandersen@clin.au.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Mikael F Vallentin
Phone
+4591174323
Email
mikvog@rm.dk
Facility Information:
Facility Name
Emergency Medical Services, the North Denmark Region
City
Aalborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas Klitgaard
Facility Name
Prehospital Emergency Medical Services, Central Denmark Region
City
Aarhus N
ZIP/Postal Code
8200
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mikael F Vallentin, MD
Facility Name
Copenhagen Emergency Medical Services, the Capital Region of Denmark
City
Ballerup
ZIP/Postal Code
2750
Country
Denmark
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fredrik Folke
Facility Name
Emergency Medical Services, the Region of Southern Denmark
City
Vejle
ZIP/Postal Code
7100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Søren Mikkelsen

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Six months after the publication of the last results, all de-identified individual patient data will be made available for data sharing.
Links:
URL
https://www.ivio.dk/
Description
Trial website

Learn more about this trial

Intravenous vs. Intraosseous Vascular Access During Out-of-Hospital

We'll reach out to this number within 24 hrs